User profiles for "author:Salvatore Minisola"

Salvatore Minisola

Professore di Medicina Interna, "Sapienza" Universitą di Roma
Verified email at uniroma1.it
Cited by 16582

European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE …

J Bollerslev, L Rejnmark, A Zahn, A Heck… - European journal of …, 2022 - academic.oup.com
This European expert consensus statement provides recommendations for the diagnosis
and management of primary hyperparathyroidism (PHPT), chronic hypoparathyroidism in …

The diagnosis and management of hypercalcaemia

S Minisola, J Pepe, S Piemonte, C Cipriani - Bmj, 2015 - bmj.com
Hypercalcaemia is a common finding in the setting of primary care, 1 as well as in
emergency departments2 and patients admitted to hospital. 3 Primary hyperparathyroidism …

Tumour-induced osteomalacia

S Minisola, M Peacock, S Fukumoto… - Nature reviews Disease …, 2017 - nature.com
Abstract Tumour-induced osteomalacia (TIO), also known as oncogenic osteomalacia, is a
rare paraneoplastic disorder caused by tumours that secrete fibroblast growth factor 23 …

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy …

DL Kendler, F Marin, CAF Zerbini, LA Russo… - The Lancet, 2018 - thelancet.com
Background No clinical trials have compared osteoporosis drugs with incident fractures as
the primary outcome. We compared the anti-fracture efficacy of teriparatide with risedronate …

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop

SJ Silverberg, BL Clarke, M Peacock… - The Journal of …, 2014 - academic.oup.com
Objective: This report summarizes data on traditional and nontraditional manifestations of
primary hyperparathyroidism (PHPT) that have been published since the last International …

Short and Long-Term Variations in Serum Calciotropic Hormones after a Single Very Large Dose of Ergocalciferol (Vitamin D2) or Cholecalciferol (Vitamin D3) in the …

E Romagnoli, ML Mascia, C Cipriani… - The Journal of …, 2008 - academic.oup.com
Context: In humans, few studies have compared the potencies of ergocalciferol and
cholecalciferol in improving and maintaining vitamin D status. Objective: Our objective was …

Vitamin D status and response to treatment in post-menopausal osteoporosis

S Adami, S Giannini, G Bianchi, L Sinigaglia… - Osteoporosis …, 2009 - Springer
Treatment with anti-resorptive agents over 13 months was associated with for three to
fivefold lower bone mineral density changes and 1.5-fold increased risk of incidence fracture …

Determinants of adherence to osteoporosis treatment in clinical practice

M Rossini, G Bianchi, O Di Munno, S Giannini… - Osteoporosis …, 2006 - Springer
Introduction Poor adherence to prescribed treatments is widespread in clinical practice and
this can lead to potentially life-threatening events. This problem is apparently very common …

[PDF][PDF] Guidelines for the diagnosis, prevention and management of osteoporosis

M Rossini, S Adami, F Bertoldo, D Diacinti, D Gatti… - …, 2016 - research.unipd.it
On behalf of the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases
(SIOMMMS) with the endorsement of Italian Society of Endocrinology (SIE) Italian Society of …

[HTML][HTML] Guidelines for the management of osteoporosis and fragility fractures

R Nuti, ML Brandi, G Checchia, O Di Munno… - Internal and emergency …, 2019 - Springer
The purpose of this document, a result of the harmonisation and revision of Guidelines
published separately by the SIMFER, SIOMMMS/SIR, and SIOT associations, is to provide …